Abamune Tablet

Get a Price/Quote

MOQ : 130 Bottles

Abamune Tablet Specification

Origin of Medicine
INDIA

Physical Form
Tablets

Recommended For
DOCTOR

Quantity
130 Boxes

Abamune Tablet Trade Information

Minimum Order Quantity
130 Bottles

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Supply Ability
1500 Bottles Per Week

Delivery Time
1 Week

Sample Available
No

Sample Policy
If order is confirmed we will reimburse the sample cost

Main Export Market(s)
Western Europe, Middle East, Africa, Asia, Australia, Central America, Eastern Europe, North America, South America

Main Domestic Market
All India

About Abamune Tablet

1. Technical Specifications

Attribute	Details
Active Ingredient	Abacavir Sulfate
Strength	300 mg per tablet
Packaging Size	30 tablets per bottle or strip (varies by pack)
Packaging Type	HDPE bottle or blister pack in carton
Medicine Type	Allopathic (Antiretroviral)
Brand	Abamune Tablet
Manufactured By	Cipla Ltd.
Distributed By	Authorized pharmaceutical distributors

2. Product Description

Abamune Tablet contains Abacavir, a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV-1 infection. It works by blocking the activity of reverse transcriptase, an enzyme crucial for viral replication, thereby reducing viral load and improving immune function.

It is usually prescribed as part of a combination antiretroviral therapy (ART) for effective management of HIV.

3. Product Highlights

Attribute	Details
Generic Name	Abacavir
Strength	300 mg
Dosage Form	Oral tablet
Therapeutic Category	Antiretroviral (NRTI class)
Application Area	Management of HIV-1 infection
Administration	Orally, with or without food, usually in combination with other antiretroviral drugs
Storage Conditions	Store below 30C, protect from moisture and light

4. Therapeutic Uses

Indicated for treatment of:

Human Immunodeficiency Virus (HIV-1) infection in adults and children (as part of combination therapy)
Reduction of HIV viral load and improvement of CD4+ cell counts

5. Side Effects

Common:

Headache, nausea, vomiting
Diarrhea, abdominal pain
Fatigue, malaise
Rash, fever

Serious (rare):

Hypersensitivity reaction (HSR) potentially life-threatening; symptoms include fever, rash, gastrointestinal and respiratory symptoms
Lactic acidosis with hepatomegaly
Liver dysfunction
Exacerbation of hepatitis B (in co-infected patients after discontinuation)

6. Precautions

HLA-B*5701 screening is mandatory before initiation to avoid risk of hypersensitivity reaction
Discontinue immediately if hypersensitivity reaction is suspected; do not re-challenge
Use with caution in patients with liver disease, renal impairment, or cardiovascular risk factors
Monitor liver function, renal function, and viral load regularly during therapy
Should not be used as monotherapy; always in combination with other antiretroviral agents
Safe sex practices and adherence to therapy are essential to prevent resistance and transmission